ALKERMES | ALKS - Zapasy





Zapasy Zmiana Data
AbbVie USD 5.05B 98M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Amgen USD 6.19B 39M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
J&J USD 14.58B 392M 2026-03
Merck USD 6.48B 179M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Otsuka Holdings JPY 374.32B 23.79B 2025-12
Pfizer USD 10.67B 13M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03